BioMarin Pharmaceutical
BMRN
HK$457.06
Share price
0.15%
Change (1 day)
-30.41%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Total assets
Total assets on the balance sheet as of March 2025 : HK$56.09 Billion
According to BioMarin Pharmaceutical's latest financial reports the company's total assets are HK$56.09 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
BioMarin Pharmaceutical - Total assets on balance sheet (from 2001 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | HK$54.25 B | 1.54% |
| 2023-12-31 | HK$53.43 B | 7.27% |
| 2022-12-31 | HK$49.81 B | 6.38% |
| 2021-12-31 | HK$46.82 B | 3.28% |
| 2020-12-31 | HK$45.33 B | 24.12% |
| 2019-12-31 | HK$36.52 B | 5.36% |
| 2018-12-31 | HK$34.66 B | -4.23% |
| 2017-12-31 | HK$36.19 B | 16.01% |
| 2016-12-31 | HK$31.20 B | 7.95% |
| 2015-12-31 | HK$28.90 B | 50.55% |
| 2014-12-31 | HK$19.20 B | 10.34% |
| 2013-12-31 | HK$17.40 B | 43.14% |
| 2012-12-31 | HK$12.15 B | 19.87% |
| 2011-12-31 | HK$10.14 B | 3.21% |
| 2010-12-31 | HK$9.82 B | 38.17% |
| 2009-12-31 | HK$7.11 B | 1.5% |
| 2008-12-31 | HK$7.00 B | 10.22% |
| 2007-12-31 | HK$6.35 B | 76.36% |
| 2006-12-31 | HK$3.60 B | 138.03% |
| 2005-12-31 | HK$1.51 B | -16.36% |
| 2004-12-31 | HK$1.81 B | -8.88% |
| 2003-12-31 | HK$1.98 B | 130.33% |
| 2002-12-31 | HK$0.86 B | -35.61% |
| 2001-12-31 | HK$1.33 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Ultragenyx Pharmaceutical RARE | HK$10.29 B | -81.64% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | HK$0.67 B | -98.79% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | HK$2.54 B | -95.47% | 🇺🇸 USA |
 Sanofi SNY | HK$1.120 T | 1,896.53% | 🇫🇷 France |
 Amicus Therapeutics
FOLD | HK$6.19 B | -88.95% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | HK$7.13 B | -87.28% | 🇺🇸 USA |